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Abstract. 
 
b
 
-Catenin is an important regulator of cell–
cell adhesion and embryonic development that associ-
ates with and regulates the function of the LEF/TCF 
family of transcription factors. Mutations of 
 
b
 
-catenin 
and the tumor suppressor gene, adenomatous polyposis 
coli, occur in human cancers, but it is not known if, and 
by what mechanism, increased 
 
b
 
-catenin causes cellular 
transformation. This study demonstrates that modest 
overexpression of 
 
b
 
-catenin in a normal epithelial cell 
results in cellular transformation. These cells form colo-
nies in soft agar, survive in suspension, and continue to 
proliferate at high cell density and following 
 
g
 
-irradia-
tion. Endogenous cytoplasmic 
 
b
 
-catenin levels and sig-
naling activity were also found to oscillate during the 
cell cycle. Taken together, these data demonstrate that 
 
b
 
-catenin functions as an oncogene by promoting the 
G
 
1
 
 to S phase transition and protecting cells from sus-
pension-induced apoptosis (anoikis).
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b
 
-C
 
ATENIN
 
 is a 92–97-kD protein associated with the
intracellular tail of the intercellular adhesion molecule
E-cadherin (Ozawa et al., 1989). Through this association,
 
b
 
-catenin plays an important role in strong cell–cell adhe-
sion as it links E-cadherin (and other members of the cad-
herin family) to the actin cytoskeleton through the protein
 
a
 
-catenin (Hirano et al., 1992; Kemler, 1993). One mecha-
nism by which cell–cell adhesion can be negatively regu-
lated is via the phosphorylation of 
 
b
 
-catenin on tyrosine
residues (Behrens et al., 1993). There are some indications
that this may be an important event in the transition from
a benign tumor to an invasive, metastatic cancer (Som-
mers et al., 1994).
 
b
 
-Catenin is also a regulator of embryogenesis, a role
that was first suspected when it was shown to be the mam-
malian homolog of the 
 
Drosophila
 
 segment polarity gene
 
Armadillo
 
 (Peifer et al., 1992). Further studies in 
 
Dro-
sophila
 
 and 
 
Xenopus
 
 have revealed that 
 
b
 
-catenin is a
component of the highly conserved Wnt/Wingless signal
transduction pathway that regulates body patterning in
both species (Peifer, 1995; Gumbiner, 1997).
 
The membrane-associated and cytoplasmic pools of 
 
b
 
-cat-
enin have disparate activities: adhesion and signaling,
respectively. The accumulation of cytoplasmic 
 
b
 
-catenin
drives its interaction with members of the LEF/TCF fam-
ily of nuclear transcription factors that results in altered
gene expression, which is the transduction of the Wnt/Wg
signal (Clevers and van de Wetering, 1997). This accumu-
lation of cytoplasmic 
 
b
 
-catenin is regulated at the level of
its degradation (Peifer et al., 1994; Peifer, 1995; Papkoff et al.,
1996). In the absence of the Wnt/Wg signal, phosphoryla-
tion of specific serine residues on 
 
b
 
-catenin leads to its
ubiquitination and degradation, removing it from the cyto-
plasm (Orford et al., 1997). Mutations of these serine resi-
dues inhibit the ubiquitination of 
 
b
 
-catenin, which causes
it to accumulate and signal constitutively (Morin et al.,
1997; Orford et al., 1997).
Along with its position in a growth factor signaling path-
way, the demonstration of an interaction between 
 
b
 
-cat-
enin and the product of the tumor suppressor gene,
adenomatous polyposis coli (APC)
 
1
 
, suggests that it is in-
volved in oncogenesis (Rubinfeld et al., 1993; Peifer,
1997). Tumor cell lines with a loss of one copy of APC,
and harboring mutations in the other allele, have high lev-
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els of cytoplasmic (signaling) 
 
b
 
-catenin, which is markedly
reduced when functional APC is reintroduced (Mune-
mitsu et al., 1995). Importantly, all mutant forms of APC
found in human cancers are unable to reduce 
 
b
 
-catenin
levels in these cells. The importance of elevated 
 
b
 
-catenin
in human cancer was further substantiated when muta-
tions in the 
 
b
 
-catenin gene were described in colon cancer
and melanoma cell lines (Korinek et al., 1997; Morin et al.,
1997; Rubinfeld et al., 1997). At least one of these muta-
tions results in a more stable form of the protein.
A retroviral insertion screen for oncogenes using the
NIH-3T3 cell line also implicated 
 
b
 
-catenin as a possible
oncogene, as the insertion of the retrovirus resulted in the
expression of a 
 
b
 
-catenin protein that lacked the NH
 
2
 
 ter-
minus (Whitehead et al., 1995). In contrast, overexpres-
sion of a stabilized form of 
 
b
 
-catenin is unable to mimic
the morphological effects of Wnt-1 in fibroblasts (Young
et al., 1998).
Although much is now known about this signaling sys-
tem, the actual cellular processes in which 
 
b
 
-catenin plays
a regulatory role is unclear. As described above, it regu-
lates cadherin-mediated cell–cell adhesion. Although it
appears to regulate gene expression, few target genes have
been demonstrated. Based on its relationship with Wnt
and APC, it is possible that 
 
b
 
-catenin may positively regu-
late cellular proliferation or inhibit apoptosis. It is also
tempting to speculate that the adhesive and the putative
oncogenic functions of 
 
b
 
-catenin are related and that it
may be, at least in part, the mechanistic link between cell–
cell adhesion, contact inhibition, and/or apoptosis. How-
ever, no studies have directly tested the hypothesis that
 
b
 
-catenin is actually oncogenic.
This report utilizes the MDCK cell line to determine the
impact of overexpressing wild-type or a stabilized mutant
form of 
 
b
 
-catenin in nontransformed epithelial cells. The
data demonstrate that 
 
b
 
-catenin alters cell cycle progres-
sion and confers enhanced growth in soft agar, a surrogate
marker for tumorigenicity. In addition, 
 
b
 
-catenin confers
resistance to suspension-mediated apoptosis (anoikis), ra-
diation-induced cell cycle arrest, and allows cells to con-
tinue cycling when cultured at confluence. In short, 
 
b
 
-cat-
enin functions as an oncogene in the MDCK normal
epithelial cell line.
 
Materials and Methods
 
Cells, Plasmids, and Stable Transfections
 
MDCK cells are a canine kidney-derived nontransformed epithelial cell
line that are maintained in DME (GIBCO BRL), supplemented with 5%
FBS. A1N4 cells are a human mammary nontransformed epithelial cell
line that are grown in IMEM, supplemented with 0.5% FBS, 0.5% hydro-
cortisone, 5 
 
m
 
g/ml insulin, and 10 ng/ml EGF (Stampfer and Bartley,
1988). These cells synchronize in G
 
0
 
 in the absence of EGF. The wild-type
(WT) and S37A mutant (S37A) 
 
b
 
-catenin plasmids were described previ-
ously (Orford et al., 1997). The bacterial chloramphenicol acetyltrans-
ferase gene driven by the CMV promoter of the pcDNA 3 plasmid (In-
vitrogen Corp.) served as the negative control (CON). For stable
transfections, 800,000 MDCK cells were plated per 100-mm tissue culture
plate. The next day, 15 
 
m
 
g of the various plasmids were transfected using
the lipofectamine PLUS method (GIBCO BRL): 32 
 
m
 
l lipofectamine and
45 
 
m
 
l PLUS reagent. All of the plasmids included the neomycin-resistance
cassette for selection. 48 h later, the cells were split 1:20 and cultured for
2 wk in the presence of 500 
 
m
 
g/ml of Geneticin (GIBCO BRL). An ap-
proximately equal number of colonies grew up for each transfected plas-
mid. For each transfection, all of the colonies were trypsinized and com-
bined to give stable cell pools.
 
Immunoblotting
 
Whole cell and cytoplasmic lysates were made and immunoblotting per-
formed as described previously (Orford et al., 1997).
 
Immunofluorescence 
 
Cells were grown to confluence in 4-well BIOCOAT chamber slides (Fal-
con Plastics). Cells were washed twice in PBS and fixed in 4% paraformal-
dehyde in PBS for 10 min. Cells were then permeabilized in 0.2% Triton
X-100, 4% paraformaldehyde in PBS for 10 min. After washing in PBS,
cells were blocked in 3% ovalbumin for 1 h. The chambers were incubated
with primary antibodies overnight at 4
 
8
 
C. After washing in PBS five times
for 5 min each, fluorescein- or Texas red-conjugated secondary antibodies
were added for 1 h. Primary and secondary antibodies were diluted in 6%
normal goat serum. After removal of the secondary antibody, the cham-
bers were washed five times for 5 min in PBS, and the chambers removed.
The cells were mounted with Vectashield (Vector Labs, Inc.).
 
Antibodies
 
The anti–
 
b
 
-catenin (C19220) and anti-p27 (K25020) mAbs were from
Transduction Laboratories. The antihemagglutinin mAb (HA-11) was
purchased from Berkeley Antibody Co., Inc. A second high affinity anti-
HA mAb was purchased from Boehringer Mannheim Corp. (#186723).
The anti–E-cadherin (SHE78-7) mAb was purchased from Zymed Labs,
Inc. Peroxidase- and fluorescein-labeled secondary antibodies were pur-
chased from Kirkegaard and Perry Laboratories, Inc. The Texas red-
labeled secondary antibody was purchased from Jackson Immuno-
Research Laboratories, Inc.
 
b
 
-Catenin–LEF/TCF Signaling Assays 
 
In 12-well dishes, cells were transfected with 0.5 
 
m
 
g of the TOPFLASH
LEF/TCF reporter plasmid (van de Wetering et al., 1997) and 0.005 
 
m
 
g of
the constitutively expressed Renilla luciferase, as a normalization control.
As a negative control, cells were transfected with the FOPFLASH re-
porter plasmid in which the LEF/TCF binding sites have been mutated.
The cells were lysed and assayed for Firefly and Renilla luciferase activi-
ties using the STOP & GLO assay (Promega Corp.). All results are nor-
malized to the Renilla luciferase activity.
 
Soft Agar Growth Assay
 
For each cell pool, 150,000 cells were suspended in 3 ml DME 
 
1
 
 5% FBS,
and warmed to 37
 
8
 
C. 300 
 
m
 
l of a prewarmed (52
 
8
 
C) 3% agarose/PBS solu-
tion was mixed with the cell suspension and then layered into 3 wells of a
6-well plate (1 ml/well), which were previously coated with 1 ml of 0.6%
agarose in DME. The agar was allowed to solidify at room temperature
for 20 min before 3 ml of growth medium was added to each well. The me-
dium was changed every three days. After 14 d, the colonies were counted
by an Omnicon 3600 Colony Counter and photographed.
 
Growth Curves 
 
To have an equal number of cells plated at the first time point, 10,000
CON, and 5,000 WT and S37A cells were plated per well of 12-well plates.
At each time point, the cells were washed once in PBS and trypsinized in
1 ml trypsin/versene (GIBCO BRL). The single cell suspension was
counted on a Coulter Counter set at 10 
 
m
 
m min with 20-
 
m
 
m maximum di-
ameter. Each data point was performed in triplicate.
 
Plating Efficiency Assay 
 
For each cell pool, 100 cells were plated onto each of three 100-mm tissue
culture dishes in DME 
 
1
 
 5% FBS. 4 d after plating, the colonies were
photographed at 400
 
3
 
. After 8 d, the cells were washed with PBS, stained
with crystal violet, and washed with water. The colonies were counted and
then photographed. The plating efficiency is the mean number of colonies
per dish/100 cells plated per dish.
 
Quantification of Cell Shedding 
 
Cells were cultured in 6-well plates 3 d after confluence. The cells were 
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washed twice in PBS and 2 ml of fresh medium was added to each well. 24 h
later, the shed cells were removed with medium and counted on a Coulter
Counter, as described.
 
Cell Cycle Analyses 
 
Two flow cytometric assays were used. 
 
Vindelov Method.  
 
Cells were washed in PBS and trypsinized. Cells
were washed in PBS and pelleted. After removing the wash buffer, the
pellet was vortexed and resuspended in 0.1 ml of citrate/DMSO buffer
(250 mM sucrose, 40 mM Na
 
3
 
C
 
6
 
H
 
5
 
O
 
7
 
 2H
 
2
 
O, 5% DMSO, pH 7.60). The
pellets were then frozen at 
 
2
 
80
 
8
 
C. The cells were then processed as in
Vindelov et al. (1983).
 
Ethanol Fixation Method.  
 
Cells were washed once in PBS and tryp-
sinized. Trypsinized cells were pelleted at 1000 
 
g
 
 and washed in 5 ml cold
PBS. After a second centrifugation, the cells were resuspended in 0.5 ml
cold PBS and fixed by dripping in 1.5 ml cold 100% ethanol, while slowly
vortexing the cell suspension. After at least 1 h at 4
 
8
 
C, the cells were
stained with propidium iodide and DNA content was measured by flow
cytometry. The ethanol fixation method was also used for the flow cyto-
metric analysis of apoptosis.
 
Cell Synchronization Experiments 
 
b
 
-Catenin Protein Level.  
 
A1N4 cells were plated in 100-mm tissue culture
dishes and grown overnight to 
 
z
 
40% confluency. The cells were washed
three times in PBS and then maintained in the absence of EGF for 46–50 h.
This synchronized 
 
.
 
95% of the cells in the G
 
0
 
/G
 
1
 
 phase of the cell cycle.
To stimulate reentry into the cell cycle, EGF-containing medium was
added back to the cells. Parallel dishes were analyzed at each time point
for 
 
b
 
-catenin protein (whole cell or the cytoplasmic pool) and for the cell
cycle distribution.
 
b
 
-Catenin–LEF/TCF Signaling.  
 
50,000 A1N4 cells were plated per well
of 12-well dishes and transfected with 1 
 
m
 
g of the TOPFLASH reporter
plasmid and 0.01 
 
m
 
g of the Renilla control plasmid by the calcium phos-
phate method. The cells were then synchronized by EGF starvation (G
 
0
 
/
G
 
1
 
) or 1 
 
m
 
M nocodazole (G
 
2
 
/M), or treated with the proteosomal inhibi-
tor ALLN, which stabilizes 
 
b
 
-catenin. The cells were collected and the lu-
ciferase measurements were made as described.
 
Anoikis Assays 
 
Confluent cells were trypsinized into a single cell suspension. 700,000 cells
were plated in 150-mm tissue culture dishes coated with 0.8% agarose, to
which they could not attach. At the various time points, the cells were col-
lected, washed in PBS, and any cell aggregates were dispersed by
trypsinization. Cells were then analyzed for apoptosis using three separate
assays. 
 
DNA/Flow Cytometry. 
 
Samples were analyzed by flow cytometry (see
Cell Cycle Analyses, Ethanol Fixation). In this analysis, the hypodiploid
peak constituted the apoptotic population. 
 
AnnexinV Labeling.  
 
Samples were stained with fluorescein-labeled An-
nexinV and propidium iodide (Trevigen) according to the manufacturer’s
protocol, and analyzed by flow cytometry. The two AnnexinV positive
quadrants of the analysis were taken as the apoptotic fraction. 
 
Hoechst Staining. 
 
Cells were fixed in 10% formalin for 10 min and
stained with Hoechst #33258 (25 
 
m
 
g/ml in PBS) for 10 min at room tem-
perature in the dark. Cells were placed on a glass slide and analyzed by
fluorescence microscopy.
 
g
 
-Irradiation 
 
750,000 CON, and 500,000 WT and S37A cells were plated in T75 tissue
culture dishes. 26 h later, the flasks were exposed to 5 Gy of 
 
g
 
-irradiation.
Another group of flasks received a mock irradiation (0 Gy). At 8 and 24 h
after irradiation, the cells were trypsinized and their cell cycle profile was
determined.
 
Results
 
Expression of 
 
b
 
-Catenin Transgenes in MDCK Cells
 
To investigate the effects of 
 
b
 
-catenin on normal cellular
function, MDCK cells were stably transfected with consti-
tutively expressed 
 
b
 
-catenin transgenes that have been en-
gineered to contain a COOH-terminal HA tag. In addition
to WT 
 
b
 
-catenin, a construct harboring a previously de-
scribed serine to alanine point mutation at residue 37
(S37A) was used, which encodes for a 
 
b
 
-catenin protein
largely resistant to ubiquitination (Orford et al., 1997).
The cells used are pooled stable transfectants; that is, after
selection with G418, all of the drug resistant colonies
resulting from each transfection were combined. These
will be referred to as cell pools. As a negative control, a
cell pool expressing the bacterial chloramphenicol acetyl
transferase gene was generated (CON). Stable cell pools
were generated to avoid the phenotypic artifacts that can
result from the selection and propagation of individual
clones derived from single transfected cells. We found that
MDCK cells are especially prone to clonal morphological
variation.
When examined by immunoblotting, expression of the
HA tag was detectable only in the cell pool expressing the
more stable S37A mutant (Fig. 1, B–E). We believe that
epitope inaccessibility and antibody insensitivity result in
the poor detection of the HA-tagged 
 
b
 
-catenin and, conse-
quently, the HA tag was undetectable by immunoblotting
in untreated WT cells. To demonstrate that the WT cells
were capable of expressing HA-tagged 
 
b
 
-catenin, all three
cell pools were treated with the histone deacetylatase in-
hibitor sodium butyrate to nonspecifically increase gene
expression. This treatment resulted in clearly detectable
expression in the WT cells and very high expression in the
S37A cells, whereas the CON cells lacked expression un-
der both conditions. Sodium butyrate treatment was not
used in any other experiments in this study. In untreated
cells, a similar pattern was seen by immunofluorescence
microscopy. Using an antibody specific for the HA tag and
a fluorescein-labeled secondary antibody, staining was de-
tectable in the S37A cell pool (Fig. 1 E), but was difficult
to detect in the WT cells (data not shown). To demon-
strate the HA tag in the WT cells, a high affinity anti-HA
antibody (Boehringer Mannheim) and a Texas red-conju-
gated secondary antibody was used to increase the sensi-
tivity of the assay. Under these conditions, expression of
the HA-tagged protein was clearly demonstrable in most
of the WT cells (Fig. 1 D), even in the absence of butyrate,
whereas expression was not evident in the CON cells (Fig.
1 C). A 
 
b
 
-catenin specific antibody revealed a normal
staining pattern in all three cell pools (Fig. 1, F–H).
Whole cell lysates do not exhibit any significant increase
in total 
 
b
 
-catenin levels (data not shown) because MDCK
cells express a large amount of endogenous 
 
b
 
-catenin,
most of which is complexed with E-cadherin at the cell
membrane. However, it is the cytoplasmic pool that is in-
volved in 
 
b
 
-catenin signaling and an increase in this pool
was evident in both WT and S37A expressing cells, as
compared with the CON cell pool (Fig. 1 A).
To confirm that 
 
b
 
-catenin was being functionally over-
expressed in both the WT and S37A cell pools, LEF/TCF-
dependent nuclear signaling was measured using the TOP-
FLASH reporter construct (van de Wetering et al., 1997).
This reporter consists of four consensus LEF/TCF binding
sites placed upstream of the cFos minimal promoter. As
a negative control, a similar reporter construct (FOP-
FLASH), in which the LEF/TCF binding sites have been 
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mutated, was used. Even though the HA tag was not easily
detected in the untreated WT cell pool, LEF/TCF signal-
ing is elevated well above the control (Fig. 1 I, CON) in
both the WT and S37A cell pools.
 
b
 
-Catenin Overexpression Alters Cell Morphology
 
Overexpression of b-catenin in MDCK cells previously
was shown to alter cell morphology. The stable cell pools
used in this report have essentially the same morphology
as the MDCKs expressing an inducible form of NH2 termi-
nally truncated b-catenin (Barth et al., 1997). The WT and
S37A cell pools are less efficient at forming tight colonies
of cells, as compared with CON cells (Fig. 2). In addition,
the cells along the edges of the WT and S37A colonies
tend to extend projections more readily, giving them a
more mesenchymal morphology. The morphology of these
cell pools also varied at high density. In contrast to their
appearance at lower density, the WT and S37A cells ap-
peared to be more tightly adherent to each other (data not
shown). This is supported by the fact that these cells are
significantly slower to round up when trypsinized during
normal cell passaging. To confirm that expression of the
b-catenin transgenes did not prevent strong intercellular ad-
hesion, the ability of the WT and S37A cells transepithelial
resistance was measured in the presence and absence of
Ca21. Both the WT and S37A cells formed a strong barrier
in the presence of Ca21 (.1,000 ohms/chamber) that was
completely diminished in the absence of Ca21. These re-
sults are consistent with what is seen in normal epithelial
cell lines and confirms strong cadherin-mediated adhesion.
b-Catenin Stimulates Cell Proliferation
To characterize the distribution of these cells in the cell cy-
cle, DNA/flow cytometry analysis was performed on these
cells during exponential growth phase. Both of the b-cate-
nin overexpressing cell pools had a reduced proportion of
G0/G1 cells and an increased proportion of S and G2 cells,
as compared with the control cells (Fig. 3 A). This suggests
that either a greater proportion of the WT and S37A cells
are cycling or the G1 phase of the cycle is shorter in dura-
tion than it is in the CON cells.
Growth curves demonstrated a significant difference be-
tween the b-catenin overexpressing cells (WT and S37A)
and the CON cells (Fig. 3 B). The curves depicting the
growth of the WT and S37A cell lines diverged from that
of the CON cells, demonstrating that the alterations in cell
cycle distribution resulted in increased growth. Also, over-
expression of b-catenin increased saturation density of
these cells (Fig. 3 B, inset). Together with the demonstra-
tion that the WT and S37A cells proliferate more rapidly
at confluence (Fig. 4), it is clear that b-catenin overexpres-
sion significantly diminishes the property of contact inhibi-
tion of growth.
Interestingly, in every replication of this experiment, the
number of cells in the WT and S37A wells was elevated
(up to 50%) above the CON cells at the first time point of
the growth curve. To determine if a difference in plating
efficiency might explain the discrepancy in the cell number
on the first day of the growth curves, 100 cells were plated
per 100-mm tissue culture dish in three dishes for each cell
pool. The colony count provides a rough estimate of the
Figure 1. Expression of transgenes in MDCK stable cell pools.
A, Equal protein from cytoplasmic extracts of CON, WT, and
S37A cell pools was immunoblotted with an anti–b-catenin anti-
body. Amino black staining of nitrocellulose membrane demon-
strates equal protein loading. B, Expression of HA-tagged b-cat-
enin was determined by immunoblotting equal protein from
whole cell lysates of the three cell pools cultured with and with-
out sodium butyrate (But; to enhance gene expression) with anti-
HA antibody (HA-11; BabCo). C–E, HA-tagged b-catenin can
be detected in the WT (D) and S37A (E) cell pools by immuno-
fluorescence. The HA-tag is absent in the CON cell pool (C).
F–H, Expression of b-catenin in the same cell pools. I, b-catenin
signaling activity was determined with the TOPFLASH LEF/
TCF-responsive reporter construct. b-Catenin–LEF/TCF signal-
ing is elevated above CON in both the WT and S37A cells. The
negative control FOPFLASH reporter is essentially unaffected
by b-catenin transfection.Orford et al. b-Catenin Transforms a Normal Epithelial Cell Line 859
plating efficiency of the cells. This experiment revealed a
small (but not statistically significant) difference in plating
efficiency that may contribute to the consistent differences
in cell number, but does not explain them entirely (Fig. 3
C). We believe that the combination of increased plating
efficiency and elevated proliferation rate account for the
differences seen at the first time point.
An obvious increase in the rate of colony growth in the
b-catenin overexpressing cells was more dramatic. The
colonies from the WT and S37A cells were many fold
larger than those from the CON cells. The morphology of
these clones provides one explanation for the difference in
colony size (Fig. 3, D, E, and F). Whereas the CON cells
formed tightly adhesive, epithelioid colonies (Fig. 3 G),
the WT and S37A cells formed a large number of colonies
containing a more scattered, mesenchymal phenotype
(Fig. 3 H). The morphological changes suggest that en-
hanced motility may contribute to this dramatic increase
in colony size, but this is speculative. Also, the reduced ad-
hesiveness in the WT and S37A cells may promote large
colony formation by avoiding the contact inhibitory effect
of tight cell–cell adhesion. In addition, other data suggest
that the WT and S37A cells have an increased prolifera-
tive rate, even in the presence of strong intercellular adhe-
sion (Fig. 4).
b-Catenin Promotes Proliferation at High Cell Density
The reduction in proliferative rate that nontransformed
cells experience at high cell density has been termed con-
tact inhibition of growth. Although this is a widely recog-
nized phenomenon, the signaling mechanisms involved re-
main unknown. To address this, the MDCK cell pools
Figure 2. Exogenous b-cate-
nin expression alters mor-
phology of MDCK cells.
Phase-contrast photographs
of CON (A), WT (B), and
S37A (C) cell pools demon-
strate the effect of b-catenin
overexpression on MDCK
cell pools. b-Catenin-express-
ing cells show a more spindly,
mesenchymal, less cell–cell
adhesive morphology com-
pared with the control cells.
Figure 3. b-Catenin overexpression alters proliferation, plating
efficiency, and colony morphology. A, DNA/flow cytometric
analysis of the three cell pools during exponential growth demon-
strates that the WT and S37A cell pools have a significantly lower
percentage of cells in the G0/G1 phase of the cycle and a higher
percentage in both S and G2 phases of the cell cycle. B, Growth
curves reveal that WT and S37A cells proliferate more rapidly
than CON cells. To have approximately equal numbers of cells at
time 0, 10,000 CON, 5,000 WT, and 5,000 S37A cells were plated
per well in 12-well tissue culture plates. Each time point was done
in triplicate. Graphing and SD calculations were performed with
Sigmaplot. Error bars are hidden by symbols at several time
points. Inset, saturation density of the three cell pools. Cells were
counted at absolute confluence in 12-well plates. Each measure-
ment is the mean of the cell counts from at least six wells. Graph-
ing and SD calculation was performed with Sigmaplot. C–H,
Plating efficiency assay reveals changes in colony morphology.
100 cells from each of the cell pools were plated in 100-mm
dishes. After eight days, the colonies were stained with crystal vi-
olet, counted, and photographed. C, Number of colonies counted
for each of the three cell pools. D–F, Photographs of crystal vio-
let stained CON (D), WT (E), and S37A (F) colonies. G and H,
Phase-contrast photographs of representative colonies from the
CON (G) and WT (H) cell pools at four days. S37A colonies
looked identical to the WT colony pictured. All experiments
were performed at least three times with consistent and repeat-
able results. The Journal of Cell Biology, Volume 146, 1999 860
were grown to confluence and cell cycle parameters were
monitored. Pilot experiments revealed that the WT and
S37A cells shed more cells into the medium than CON
cells. To quantify this effect, cells that were two to three
days after confluence were washed twice with PBS, and
fresh medium was added. The medium was collected from
the wells on the next day and the suspended cells were
counted. The number of shed cells was markedly elevated
in the WT and S37A cells, as compared with the CON cells
(Fig. 4 A). In these experiments, shedding of the S37A cell
pool was consistently higher than in the WT cell pool.
The hypothesis that a higher proliferative rate was re-
sponsible for the difference in cell shedding was tested by
performing cell cycle analysis of these cells grown three
days after confluence. This analysis demonstrated that the
WT and S37A cells had a higher proportion of S phase and
G2 phase, and a lower percentage of G0/G1 phase, as com-
pared with the CON cells (Fig. 4 B). This cell cycle profile
is precisely what would be expected if the WT and S37A
cells were proliferating more rapidly than the CON cells,
and is consistent with other experiments in which the G1/S
checkpoint control regulates contact inhibition (Dietrich
et al., 1997; Kato et al., 1997). Presumably, in the absence
of additional space to attach to the culture dish, the newly
formed cells are shed into the medium.
b-Catenin Attenuates the Radiation-induced G1/S Cell 
Cycle Block
One important aspect of cell cycle regulation is cell cycle
blockade after DNA damage. These blocks, which occur
at the G1/S and G2/M transitions, presumably allow the
cell to repair its DNA before the damage-induced errors
become permanent (Weinert, 1998). We postulated that
b-catenin overexpression might alter the DNA damage-
induced late G1 block of the cell cycle in the MDCK cells.
The three cell pools were g-irradiated with 0 or 5 Gy.
Eight hours after irradiation, all of the cell pools show
some G1/S and G2/M cell cycle blockade (Fig. 5). How-
ever, while CON had very few S-phase cells (5.96%), the
WT and S37A cells retained a significant number of cells
in S phase (15.26 and 14.99%). 24 h after irradiation, 25.2
and 21.4% of the WT and S37A cells, respectively, were
in S phase, compared with 0.77% of CON cells. These
data demonstrate that the radiation-induced G1/S block is
strongly attenuated by the overexpression of b-catenin
and indicates that elevated b-catenin might lead to the ac-
cumulation of DNA damage and increased incidence of
other mutations.
b-Catenin Expression Fluctuates throughout the
Cell Cycle
The previously described block of G1/S progression by
APC in normal cells points to a role of endogenous b-cate-
nin in the regulation of cell cycle progression in nontrans-
formed cells (Baeg et al., 1995). Together, with our dem-
onstration that even the modest elevations of b-catenin
described in this study can regulate cell cycle progression,
Figure 4. b-Catenin overex-
pression promotes prolifera-
tion at high cell density. A,
Cells were cultured three
days after confluence. After
washing, cell shedding was
measured over a 24 h period
by counting the number of
cells suspended in the me-
dium. Graphing and SD cal-
culation were performed us-
ing Sigmaplot. B, Cell cycle
profiles of cells grown three days after confluence. After cells were washed twice with PBS, cell cycle analysis was performed on the ad-
herent cells. The S phase percentage is increased 2–2.5-fold in WT and S37A cells relative to CON. All experiments were performed at
least three times with consistent and repeatable results.
Figure 5. b-Catenin overexpression attenuates the g-irradiation
G1 cell cycle block. Cells were g-irradiated with 0 or 5 Gy. 8 and
24 h later, the cell cycle distribution was determined. The unirra-
diated cells all had a similar profile with the characteristic differ-
ences in G0/G1 and S phases (see Fig. 3). The S phase population
of CON cells is significantly reduced at 8 h and absent at 24 h. At
24 h, the CON cells were blocked entirely in the G0/G1 or G2
phases of the cell cycle. A slight decline in the proportion of WT
and S37A cells in S phase occurs at 8 h after irradiation, but this is
much less than that which occurs in CON cells. In contrast to
CON cells, at 24 h the S phase proportions of the WT and S37A
cells have partially recovered. All experiments were performed
at least three times with consistent and repeatable results.Orford et al. b-Catenin Transforms a Normal Epithelial Cell Line 861
this led us to investigate its level of expression throughout
the cell cycle. Preliminary experiments were performed
with parental MDCK cells that were partially synchro-
nized in early G1 by serum starvation. Parallel wells of
cells were collected at various time points after release
from G0 by the addition of serum to make whole cell or cy-
toplasmic lysates for analysis of b-catenin protein levels.
Although total b-catenin protein did not vary appreciably
during the cell cycle, cytoplasmic b-catenin levels in-
creased significantly from G1 to S phase (data not shown).
The increase began in late G1 and continued through S
phase. These pilot experiments led us to examine this phe-
nomenon in the A1N4 cell line, which is easily synchro-
nized in early G1 by the removal of EGF from the growth
medium. Like MDCK cells, cytoplasmic levels of b-cate-
nin protein increased in late G1 and continued to rise in S
phase (Fig. 6 A), whereas total cell b-catenin did not vary
(data not shown). Densimetric scanning revealed a 23-fold
increase in cytoplasmic levels from early G1/G0 to S phase
(Fig. 6 B). As a control, the blot was reprobed for cyclin
dependent kinase inhibitor, p27 (Fig. 6 A). As expected,
variations in p27 were inversely related to b-catenin. To
determine if this oscillation in cytoplasmic b-catenin led to
fluctuations in b-catenin–LEF/TCF signaling, A1N4 cells
were assayed for TOPFLASH activity after being synchro-
nized in G1 phase or G2/M phase of the cell cycle. The
level of b-catenin–LEF/TCF signaling corresponded with
the levels of cytoplasmic b-catenin measured by Western
blotting (Fig. 6 C). The elevation in signaling at G2/M was
greater than that induced by treatment with the proteoso-
mal inhibitor, ALLN. These data indicate that oscillations
in b-catenin signaling may be involved in the normal regu-
lation of cell cycle progression.
b-Catenin Promotes Colony Formation in Soft Agar
The ability of cells to proliferate in the absence of attach-
ment to a solid substrate correlates well with the trans-
formed, tumorigenic phenotype. To assess the oncogenic
capacity of b-catenin in vitro, cells were suspended in
0.3% agar and allowed to grow for two weeks. The ability
of the WT and S37A cells to form colonies in soft agar was
clearly enhanced relative to the CON cells (Fig. 7, A–C).
Although the CON cells do exhibit a background level of
colony formation, expression of the b-catenin transgenes
resulted in a 10–20-fold increase in the number of colonies
and an obvious increase in colony size (Fig. 7 D). Multiple
experiments did not demonstrate a significant difference
between the WT and S37A cell pools. This is the first dem-
onstration that full-length b-catenin, WT and S37A mu-
tant, has transforming capacity.
b-Catenin Inhibits Anoikis
When nontransformed epithelial cells are deprived of at-
tachment to an extracellular matrix for an extended period
of time they undergo apoptosis (Frisch and Francis, 1994;
Figure 6. Cytoplasmic b-catenin oscillates during the cell cycle.
A, A1N4 cells were synchronized in G0/G1 by EGF starvation.
After releasing the cells into the cell cycle by the addition of
EGF, cytoplasmic lysates were made every 3 h and assayed for
b-catenin and p27 protein by immunoblotting. The distribution of
cells in the cell cycle was determined at each time point by ana-
lyzing parallel cell cultures by flow cytometry. The percentage of
S phase cells (%S) is provided. B, The level of expression was de-
termined at each time point by densitometry and the results plot-
ted against time after EGF addition. C, b-catenin–LEF/TCF sig-
naling was measured in cells that were blocked in G0/G1 by EGF
starvation (2EGF), growing asynchronously (Asynch), blocked
near the S/G2 transition by the proteosomal inhibitor ALLN, or
blocked at G2/M with nocodazole (Nocod). The results are ex-
pressed relative to the G0/G1 synchronized samples. Experiments
represented in A and B were performed three times with consis-
tent and repeatable results. Experiments represented in C were
performed twice with consistent and repeatable results.
Figure 7. b-Catenin overexpression regulates soft agar colony
formation. A–C, Phase-contrast photographs of colonies formed
by the CON (A), WT (B), and S37A (C) cell pools after 14 d in
soft agar. D, The number of colonies per 35-mm dish quantified
by the Omnicon 3600 colony counter, using either 100 or 140 mm
as the threshold for colony diameter. Experiments were repeated
three times with consistent and repeatable results.The Journal of Cell Biology, Volume 146, 1999 862
Frisch and Ruoslahti, 1997). This suspension-induced apop-
tosis has been termed anoikis. In the soft agar growth ex-
periments, it appeared that most CON cells die when sus-
pended in soft agar. However, the remaining cells did
contribute to a background rate of colony formation. To
investigate the possibility that b-catenin increases the
colony-forming capacity of MDCK cells by preventing
anoikis, cells were cultured on a cushion of 0.8% agar in
normal growth medium, collected at eight hour intervals
over a 24-h period, and assayed for apoptosis. Microscopic
examination of the cells after 16- and 24-h incubations re-
vealed that the majority of the WT and S37A cells were
larger and more refractile to light than the CON cells (data
not shown), suggesting that the CON cells were preferen-
tially undergoing apoptosis. These preliminary results were
confirmed by DNA/flow cytometry and AnnexinV staining
of cells that had been kept in suspension for 0, 8, or 16 h
(Fig. 8, A and B). Both methods showed that anoikis was
significantly inhibited by b-catenin overexpression.
The results of further analysis of the flow cytometry and
AnnexinV data for the percentage of hypodiploid and An-
nexinV-positive cells, respectively, are compiled in Table
I. The DNA/flow cytometry data revealed that the per-
centage of hypodiploid cells was markedly and consis-
tently lower in the WT and S37A cells relative to the CON
cells. However, these data significantly underestimate the
percentage of apoptotic cells in the CON samples at the 16 h
time point, as the disintegrating apoptotic cells were lost
from the analysis. The AnnexinV assays appeared to re-
tain these cells and probably give a more accurate estimate
at 16 h.
As a third independent method of measuring apoptosis,
nuclear morphology of cells before and after suspension
was analyzed by Hoechst staining. In contrast to the non-
suspended cells, which all had normal nuclear morphology
(Fig. 8 C), most of the suspended CON cells displayed
characteristically shrunken apoptotic nuclei (Fig. 8 D). In
contrast, the nuclei of the majority of WT and S37A cells
displayed a normal morphology (Fig. 8 E). A fraction of
the cells (z1/4) were apoptotic, which is consistent with
the AnnexinV and flow cytometry results. Interestingly, a
minority of CON cells were found to be associated with
clumps of five or more cells. Most of these cells displayed
normal nuclear morphology. This was a clear demonstra-
tion that cell–cell adhesion can prevent apoptosis induced
by suspension, and this probably caused us to underesti-
mate the percentage of apoptosis among the suspended
CON cells by the AnnexinV and flow cytometric method-
ologies.
These data demonstrate that b-catenin overexpression
may promote soft agar colony formation of MDCK cells
by the promotion of cell cycle progression and the inhibi-
tion of anoikis.
Figure 8. b-Catenin expression prevents anoikis. A, DNA/flow
cytometric analysis of CON, WT, and S37A cells after incubation
in suspension for 0, 8, or 16 h. The hypodiploid population corre-
sponds to the apoptotic cells. The percentage in each panel repre-
sents the hypodiploid fraction. B, AnnexinV and propidium io-
dide staining of the same cells at 16 h also demonstrates a
significant protection by b-catenin. C, Hoechst staining demon-
strates nuclear morphology of CON cells before suspension. All
nuclei look normal. WT and S37A cells looked similar. D,
Hoechst staining of CON cells after 16 h in suspension. Most nu-
clei have a shrunken apoptotic morphology (arrows). E, S37A
cells after 16 h in suspension. Most cells had the normal nuclear
morphology, but a significant fraction (z25%) were shrunken
apoptotic (arrows). Experiments represented in A and B were
performed at least three times with consistent and repeatable re-
sults. Experiments represented in C–E were performed twice
with consistent and repeatable results.
Table I. b-Catenin Prevents Anoikis, as Measured by
DNA/Flow Cytometry and AnnexinV Labeling
Hypodiploid cells AnnexinV positive
0 h 8 h 16 h 0 h 8 h 16 h
%%
CON 3.6 56.6 44.6 1.7 50.4 74.7
WT 1.1 14.7 19.1 2.4 18.0 21.9
MUT 0.4 22.4 24.3 0.7 31.0 24.0
The percentage of apoptotic cells in the three cell pools after different periods of sus-
pension, as measured by flow cytometry (hypodiploid) or AnnexinV labeling (Annex-
inV positive). The percentages in bold demonstrate the most notable effects.Orford et al. b-Catenin Transforms a Normal Epithelial Cell Line 863
Discussion
It is suspected that the cadherin-associated protein b-cate-
nin promotes the process of carcinogenesis (Peifer, 1997).
The data that support this hypothesis include the following
observations: it associates with and is downregulated by
the tumor suppressor APC; it transduces (at least partly)
the oncogenic Wnt growth factor signal to the nucleus; it is
mutated in a significant number of human cancers; and,
overexpression of an NH2 terminally truncated form of
b-catenin in the epidermis of transgenic mice produced well-
differentiated hair tumors (Rubinfeld et al., 1993; Su et al.,
1993; Cadigan and Nusse, 1997; Ilyas et al., 1997; Fukuchi
et al., 1998; Gat et al., 1998; Miyoshi et al., 1998; Palacios
and Gamallo, 1998; Voeller et al., 1998). However, no stud-
ies provide direct evidence for the transforming potential
of full-length b-catenin. In addition, no investigations have
addressed the question of which cellular processes b-cate-
nin may regulate to effect cellular transformation.
b-Catenin Transforms the Epithelial MDCK Cell Line
This report characterizes phenotypic alterations that result
from b-catenin overexpression in a nontransformed epi-
thelial cell line. Effects are seen in the regulation of
three important cellular activities/properties: proliferation,
apoptosis, and morphology. It demonstrates that modest
b-catenin overexpression significantly enhances the ability
of these cells to proliferate, especially in situations that
would normally inhibit the cell cycle at the G1/S transition.
Most striking is the demonstration that it promotes growth
in soft agar, a phenotype closely correlated with tumor-
igenicity. Most nontransformed cells require adhesion
through integrin receptors to extracellular matrix compo-
nents to transit through the G1 phase of the cell cycle
(Mehta et al., 1986; Polyak et al., 1994). In addition, sus-
pension of normal, attachment-dependent cells blocks
them late in G1 phase.
b-Catenin overexpression also resulted in increased pro-
liferation of cells at high cell density. The mechanism by
which high cell density inhibits proliferation is unknown,
but also involves a block in late G1. The presence of cell–
cell adhesion, the reduction of cell-substrate adhesion, and
the depletion of growth factors have all been implicated
(Chen et al., 1997). b-Catenin’s dual activities as a regula-
tor of cadherin-mediated cell–cell adhesion and as the
transducer of a mitogenic signal implicate it in this regula-
tory process. Both cadherin and a-catenin can inhibit
b-catenin signaling in other experimental systems (Fa-
gotto et al., 1996; Simcha et al., 1998). Together, with the
results of the present study, these data support the hypothe-
sis that cell–cell adhesion promotes the formation of
cadherin/b-catenin/a-catenin complexes and that these
complexes negatively regulate b-catenin signaling, which
discourages cell cycle progression. However, the fact that
proliferation is reduced at high cell density, as compared
with sparsely plated cells, even in the WT and S37A cells,
suggests that other mechanisms are also involved (for ex-
ample, cell shape; Chen et al., 1997).
The cell cycle analyses and growth curves in this study
demonstrate that b-catenin overexpression can signifi-
cantly alter the proliferative rate of these cells. The distri-
bution of the WT and S37A cells is weighted heavily to-
ward S phase and away from G1. When considered along
with the other cell cycle data, it appears that b-catenin
overexpression expedites the G1/S transition in MDCK
cells. The easing of the barrier to G1/S transition manifests
as a difference in cell growth on plastic, as growth curves
of the b-catenin overexpressing cells diverged significantly
from the control cells.
b-Catenin overexpression also has a notable effect on
cell morphology. The MDCK cell line is a nontransformed
epithelial line that has very strong intercellular adhesion
and extends cell membrane extensions only to a limited
degree. b-Catenin overexpression converts MDCKs into a
more mesenchymal cell type (Barth et al., 1997; and the
present study). At low density, cell–cell adhesion is re-
duced and the cells take on a more spindly, stretched
shape. This change in morphology is reminiscent of an epi-
thelial to mesenchymal transition (EMT; Huber et al.,
1996). EMTs are developmentally important cellular con-
versions, especially during gastrulation, the point in devel-
opment at which b-catenin knockout mouse embryos are
aborted. Also, an EMT has been suggested to underlie the
progression from benign tumor to metastatic carcinoma
(Sommers et al., 1991; Birchmeier et al., 1996). Indeed, it
previously has been suggested that b-catenin signaling
may regulate this process (Sommers et al., 1994; Huber et al.,
1996).
The absence of anoikis is another characteristic of trans-
formed cells. The present study and others have shown
that MDCK cells are very dependent on attachment to the
extracellular matrix for survival (Frisch and Francis, 1994;
Frisch et al., 1996a,b). After 16 h in suspension, the major-
ity of CON cells were apoptotic, as measured by three in-
dependent methods. The expression of the WT and S37A
b-catenin transgenes markedly retards this process, allow-
ing z75% of the single cells to survive. This is a vigorous
inhibition of anoikis. Taken together, the proliferation,
anoikis, and morphology data demonstrate that these cells
are clearly transformed by b-catenin.
These in vitro results suggest that overexpression of full-
length  b-catenin should promote tumorigenesis in vivo.
Two separate studies have demonstrated the effect of tis-
sue-specific overexpression of an NH2 terminally trun-
cated form of b-catenin. Expression of the truncated form
of b-catenin in the epidermis of transgenic mice by Gat et
al. (1998) resulted in the formation of two types of hair fol-
licle-related tumors. Taken together with the present
study, these results strongly suggest that full-length forms
of b-catenin are important mediators of oncogenesis in
vivo. Interestingly, a study by Wong et al. (1998), in which
an NH2 terminally truncated form of b-catenin was over-
expressed in the intestinal epithelium of transgenic mice,
produced conflicting results. Proliferation of the intestinal
epithelial cells in these animals was stimulated 1.5–3-fold,
in accordance with the results of the present study. How-
ever, the elevated proliferation rate was balanced by an in-
crease in apoptosis, the net result being no change in intes-
tinal villus height. To explain the discrepancy between
these results and our own, we suggest that b-catenin over-
expression can protect cells only from certain apoptotic
signals. It is possible that the compensatory mechanism
by which the authors suggested that the transgenic mice
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creased proliferation is mediated through the stimulation
of b-catenin–insensitive apoptosis. It is also possible that
full-length b-catenin has signaling capacities that are lost
when its NH2 terminus is removed.
The results presented in the present study also differ
from those published previously by Young et al. (1998).
They reported that overexpression of the Wnt-1 growth
factor transformed Rat-1 fibroblasts while expression of
the S37A mutant form of b-catenin we described previ-
ously had no effect. Two differences between the two stud-
ies may explain the conflicting results. First, the mor-
phological effects we describe may only be detectable in
an epithelial cell type. Second, the studies of Young et
al. (1998) were carried out without serum, whereas the
present ones were done with serum. It is possible that
Wnt-1 activates parallel signaling pathways (in addition to
b-catenin signaling) that may circumvent the need for se-
rum to stimulate proliferation. b-Catenin’s position lower
in the pathway may preclude the activation of such paral-
lel pathways and, therefore, it is unable to stimulate prolif-
eration of Rat-1 fibroblasts in the absence of serum.
b-Catenin Attenuates the Cell’s Response
to g-Irradiation
The cell cycle blocks that characterize the response of cells
to DNA damage are important for the maintenance of ge-
nomic integrity. To prevent the permanent incorporation
of mutations induced by various DNA damaging stimuli,
the cell cycle can pause at the G1/S and the G2/M transi-
tions (Weinert, 1998). During these delays, the cell as-
sesses the damage to its DNA and either repairs the dam-
age or destroys itself. Premature reentry into the cell cycle
may result in the accumulation of mutations to oncogenes
and tumor suppressor genes, which would increase the
likelihood of cellular transformation and cancer. The data
from this study suggest that b-catenin overexpression may
result in the premature reentry of cells into the cell cycle
after  g-irradiation–induced DNA damage, and thereby
promote the accumulation of oncogene mutations and car-
cinogenesis.
b-Catenin Overexpression Inhibits Anoikis
An association between apoptosis and the APC/b-catenin
axis has been suggested previously. Reexpression of the
APC gene in a tumor cell line that lacks WT APC resulted
in the induction of apoptosis within 24 h (Morin et al.,
1996). Since one of the functions of APC is to downregu-
late b-catenin, it is possible that b-catenin itself is a regula-
tor of apoptosis. Our demonstration that b-catenin alone
significantly protects cells from anoikis strongly implies
that it can be a potent inhibitor of apoptosis. Also, during
the process of apoptosis, caspase-3 can cleave b-catenin
protein (Brancolini et al., 1997). One purpose of this cleav-
age may be to destroy the antiapoptotic b-catenin signal
within the cell and thereby hasten the completion of the
apoptotic process. The caspase-mediated cleavage of focal
adhesion kinase (FAK) is thought to function in this man-
ner (Wen et al., 1997).
It has been postulated that the induction of apoptosis by
the loss of appropriate extracellular matrix attachment
(i.e., anoikis) is a means of protecting the organism from
improper cell growth (Frisch and Ruoslahti, 1997). Anoi-
kis is prevented by integrin-mediated signaling. Several
enzymes have been implicated as being downstream of in-
tegrins in this signal transduction pathway. These include
FAK, phosphoinositide-3-kinase, protein kinase B/Akt,
and integrin-linked kinase (ILK; Clark and Brugge, 1995;
Giancotti, 1997; Wu et al., 1998). The present report sug-
gests that b-catenin may also lie downstream of integrins.
Several integrin-stimulated signaling pathways might lead
to the induction of b-catenin signaling. One possible con-
nection between integrins and b-catenin is the integrin-
activated, antiapoptotic kinase PKB/Akt. PKB is known
to inhibit the activity of glycogen synthase kinase 3-b, a
serine kinase that functions directly to reduce b-catenin
protein and signaling (Siegfried et al., 1992; Cook et al.,
1996; Cadigan and Nusse, 1997). It is possible that the re-
sult of these two inhibitory interactions is that activation
of PKB by integrin signaling functions to positively acti-
vate b-catenin signaling.
The data presented in this report describing the effects
of b-catenin overexpression are similar to previous reports
describing the effects of ILK (Novak et al., 1998; Wu et al.,
1998). ILK is a 59-kD serine kinase that was first described
as a b1-integrin-associated kinase. ILK overexpression
causes cells to undergo an EMT and promotes their
growth in soft agar. This is associated with an increase in
LEF-1 protein levels. As a result of increased LEF-1,
b-catenin becomes completely localized to the nucleus
and b-cat-LEF/TCF signaling increases significantly. In
addition, loss of cell attachment to the underlying ECM
was shown to result in a dramatic reduction in LEF pro-
tein. In a separate study, ILK directly phosphorylated and
inhibited the activity of GSK-3b. This may constitute an-
other mechanism by which integrin signaling may result in
increased b-catenin–LEF/TCF signaling.
Anoikis results from the interruption of integrin-medi-
ated signaling (Frisch and Ruoslahti, 1997). In addition to
ILK, the integrin-associated nonreceptor tyrosine kinase
FAK may also be involved in the transduction of these sig-
nals because FAK signaling suppresses p53-dependent
apoptosis (Ilic et al., 1998). Ilic et al. (1998) also demon-
strated that an atypical protein kinase C isoform (PKCl/i)
is required for this p53-dependent apoptotic pathway,
since inhibition with both chemical PKC inhibitors and a
dominant–negative construct protect FAK-defective cells
from apoptosis. Previously, we reported that an atypical
PKC isoform was involved in regulating b-catenin degra-
dation (Orford et al., 1997). Inhibiting atypical PKC activ-
ity using the same chemical PKC inhibitors used by Ilic et
al. (1998) resulted in the inhibition of the ubiquitination
and degradation of b-catenin. In addition, treatment of
cells with these PKC inhibitors increases b-catenin–LEF/
TCF signaling (unpublished results). Taken together with
the present study, it is possible that the inhibition of
PKCl/i or another atypical PKC may increase b-catenin
stability and signaling, leading to the suppression of p53-
mediated apoptosis (Fig. 9 A).
b-Catenin Oscillations during the Cell Cycle May 
Regulate Normal Cellular Proliferation
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nin signaling pathway (He et al., 1998). The upregulation
of c-myc by b-catenin may constitute one mechanistic link
between b-catenin and tumor formation. c-myc is potent
oncogene that regulates cell cycle progression. However,
c-myc overexpression cannot induce cellular transforma-
tion on its own. In fact, when overexpressed alone, c-myc
markedly increases the susceptibility of cells to apoptosis
(Desbarats et al., 1996; Steiner et al., 1996; Thompson,
1998). To transform cells, c-myc requires an accompanying
survival signal to prevent cells from undergoing apoptosis.
Advancement through the G1 phase of the cell cycle can
result in either progression into S phase or apoptosis, de-
pending on the presence or absence of certain survival sig-
nals, for example, IGF-1 (Evan et al., 1995). In addition to
stimulating c-myc, b-catenin may transduce the requisite
antiapoptotic signal that would permit cell cycle progres-
sion. The increase of cytoplasmic b-catenin protein before
S phase during the cell cycle may serve this purpose in nor-
mal cells (Fig. 6). Additionally, b-catenin would protect
against anoikis if overexpressed in epithelial cells.
Our data do not demonstrate any reproducible pheno-
typic difference between the WT and S37A expressing
cells, except in the measurement of protein expression and
in cell shedding at confluence. It is important to note that
in both the WT and S37A cell pools, the level of cytoplas-
mic b-catenin protein and b-catenin–LEF/TCF signaling is
elevated relative to the CON cells. This implies that a
modest increase of cytoplasmic b-catenin can result in sig-
nificant changes in signaling and cellular transformation
and that overexpression of the wild-type gene alone is suf-
ficient. This may also explain how the relatively small in-
crease in endogenous cytoplasmic b-catenin that occurs
before the onset of S phase may regulate the G1/S transi-
tion in the normal cell cycle (Fig. 9 B). However, it is inter-
esting to note that the increase in signaling above CON
levels and the difference between the WT and S37A cells
are relatively small when compared with other published
results (Morin et al., 1997; Porfiri et al., 1997; Young et al.,
1998). It is possible that the fact that this study was per-
formed with cells that stably express a constitutively active
transgene is responsible for both phenomena. We believe
that the very high levels of b-catenin expression and sig-
naling that can be achieved in nontransformed cells by
transient transfection is not conducive to their survival and
propagation. If true, selection pressures against very high
expression would: result in the production of stable cells
expressing only moderately elevated b-catenin protein
and signaling; and, limit the extent to which the S37A mu-
tation could stimulate signaling above WT b-catenin. In
addition, some studies have used different b-catenin mu-
tants, which may be more active.
It is plausible that some of the phenotypic alterations in-
duced by b-catenin overexpression could be the result of
altered cadherin function and independent of b-catenin
signaling. However, the fact that these cells display strong
intercellular adhesion at high density and retain the ability
to generate tight junctions (as measured by electrical resis-
tance across the monolayer in culture) demonstrates that
E-cadherin function remains intact.
The APC/b-catenin signaling pathway has been impli-
cated in a large number of epithelial cancers (Munemitsu
et al., 1995; Inomata et al., 1996; Ilyas et al., 1997; Korinek
Figure 9. Hypothetical signaling pathways by which b-catenin
might integrate cell adhesion, cell cycle, and apoptosis. A, The in-
dividual regulatory relationships depicted by unbroken arrows
and blockades have been demonstrated in various published re-
ports. However, these signaling pathways have never been dem-
onstrated in their entirety within a single experimental system.
The broken blockades are hypothetical regulatory events sug-
gested in the present report. Integrin-activated FAK activity may
regulate b-catenin signaling by two different pathways. In both
cases, two sequential negative regulatory interactions down-
stream of FAK may result in the activation of b-catenin signaling.
By a parallel pathway, ILK can regulate the activities of PKB and
GSK-3b, as well as upregulate the expression of the transcription
factor LEF-1. Together, b-catenin and LEF-1 might stimulate the
G1/S transition in the cell cycle (possibly via c-myc) and inhibit
p53-mediated apoptosis. The inhibition of apoptosis may be
through direct modulation of p53 action or through a parallel an-
tiapoptotic pathway. The role of p53 in b-catenin–mediated sig-
naling is speculative. B, b-catenin may regulate the cell cycle by
two separate mechanisms: 1, b-catenin can stimulate the expres-
sion of c-myc, which is a strong stimulator of cell cycle progres-
sion; 2, the G1/S transition represents an important decision-
point for the cell. It is known that this transition requires the
presence of survival factors. In their absence, the cell chooses
apoptosis over proliferation. b-Catenin may regulate the G1/S
transition as a survival factor functioning to permit cell cycle pro-
gression by preventing apoptosis.The Journal of Cell Biology, Volume 146, 1999 866
et al., 1997; Mareel et al., 1997; Morin et al., 1997; Peifer,
1997; Rubinfeld et al., 1997; Palacios and Gamallo, 1998;
Voeller et al., 1998). In most cases, mutations in either
APC or b-catenin result in stabilization of b-catenin pro-
tein and elevated b-catenin–LEF/TCF signaling. How-
ever, it is not clear what role this pathway has in normal
cells. In this study, we demonstrate that b-catenin is a po-
tent oncogene. All of the major phenomena that charac-
terize cellular transformation, that is, soft agar growth, al-
tered morphology, inhibition of apoptosis, and stimulation
of cell cycle progression, can be induced by the modest
overexpression of b-catenin in a nontransformed epithe-
lial cell line. This clearly indicates that b-catenin can play a
direct role in the process of carcinogenesis and that a ma-
jor component of APC function is its downregulation.
These data suggest that, as an early event in the progres-
sion of colorectal cancer, activation of b-catenin signaling
promotes adenoma formation by promoting proliferation
and survival of epithelial cells in the abnormal tissue archi-
tecture of a tumor mass. In addition, it may also promote
the accumulation of mutations and cancer progression by
attenuating the DNA damage-induced G1 cell cycle block.
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